AU2002365236A1 - Therapeutic use for lp229, in particular for wound healing - Google Patents

Therapeutic use for lp229, in particular for wound healing

Info

Publication number
AU2002365236A1
AU2002365236A1 AU2002365236A AU2002365236A AU2002365236A1 AU 2002365236 A1 AU2002365236 A1 AU 2002365236A1 AU 2002365236 A AU2002365236 A AU 2002365236A AU 2002365236 A AU2002365236 A AU 2002365236A AU 2002365236 A1 AU2002365236 A1 AU 2002365236A1
Authority
AU
Australia
Prior art keywords
wound healing
therapeutic use
therapeutic
healing
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365236A
Other languages
English (en)
Other versions
AU2002365236A8 (en
Inventor
Josef Georg Heuer
Kristine Kay Kirkly
Eric Wen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002365236A1 publication Critical patent/AU2002365236A1/en
Publication of AU2002365236A8 publication Critical patent/AU2002365236A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002365236A 2001-01-18 2002-01-09 Therapeutic use for lp229, in particular for wound healing Abandoned AU2002365236A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26245801P 2001-01-18 2001-01-18
US60/262,458 2001-01-18
US32523301P 2001-09-27 2001-09-27
US60/325,233 2001-09-27
PCT/US2002/000487 WO2003065981A2 (fr) 2001-01-18 2002-01-09 Methodes d'utilisation therapeutiques de lp229

Publications (2)

Publication Number Publication Date
AU2002365236A1 true AU2002365236A1 (en) 2003-09-02
AU2002365236A8 AU2002365236A8 (en) 2003-09-02

Family

ID=27737161

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365236A Abandoned AU2002365236A1 (en) 2001-01-18 2002-01-09 Therapeutic use for lp229, in particular for wound healing

Country Status (3)

Country Link
EP (1) EP1545591A2 (fr)
AU (1) AU2002365236A1 (fr)
WO (1) WO2003065981A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1151113A2 (fr) * 1999-01-11 2001-11-07 Incyte Pharmaceuticals, Inc. Peptidases humaines
US20050048483A1 (en) * 2000-09-28 2005-03-03 Su Eric Wen Novel secreted proteins and their uses

Also Published As

Publication number Publication date
WO2003065981A3 (fr) 2005-04-07
EP1545591A2 (fr) 2005-06-29
WO2003065981A2 (fr) 2003-08-14
AU2002365236A8 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
AU2002342613A1 (en) Treatment for wounds
AU2002258990A1 (en) Improvements in ablation therapy
AU2002341931A1 (en) Patient directed therapy management
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002258063A1 (en) Medicament applicator
AU2002357086A1 (en) Healing abutment
AU2001277767A1 (en) Skin wound healing promoters
AU2002319286A1 (en) Skin treatment
AU2003291456A1 (en) Methods for promoting wound healing and uses thereof
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU4090301A (en) Compression bandage
AU2002335667A1 (en) Modified reoviral therapy
AU2001234270A1 (en) Bandage for orthopaedic use
AU2002365236A1 (en) Therapeutic use for lp229, in particular for wound healing
AU2002362214A1 (en) Physical therapy device
AU2001241913A1 (en) Methods for wound treatment
AU2001100046A4 (en) Bandage Roller
AU2002344975A1 (en) Wound treatment agent
AUPR563701A0 (en) Treatment and composition for wound healing
AUPQ493500A0 (en) Wound healing solution
AU2003209845A1 (en) Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
AU2002253036A1 (en) Bandage for wounds
AU2002220523A1 (en) Therapeutic treatment device
AUPS143302A0 (en) Treatment and composition for wound healing
AU2002308074A1 (en) Skin treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase